The key objectives of the Institute include the development of artificial organs and bionic prostheses, anticoagulant coatings for implants, as well as tissue engineering, intelligent diagnostics, and organs on chips.
LabCorp, a leading global life sciences company, announced that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.
Nightingale Health, the Finnish innovator of a biomarker testing technology, will analyze 40,000 blood samples from Finland's largest biobank, THL Biobank, acting under the National Institute for Health and Welfare.
ProJect Pharmaceutics, a German service provider of pharmaceutical formulations and lyophilisation processes, expands its service portfolio with laboratories for handling GMO S2 and BSL-2 biological products.
Concept Life Sciences, the integrated drug discovery, development and analytical services company, completed the first phase of its GXP compliance plan, achieving GLP accreditation of its site in Dundee, Scotland
A laboratory for early studies of pharmaceuticals intended to treat cancer will be opened in the city of Obninsk, Kaluga region. It will allow to accelerate the market launch of the modern drugs manuf...